Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/BASILEA-PHARMACEUTICA-AG-130199/news/Basilea-Pharmaceutica-berichtet-uber-Studienprotokoll-Anderung-fur-fruheren-Abschluss-der-Isav-19208042/?utm_source=whatsapp&utm_medium=social&utm_campaign=share